Total amount raised
$325.1 Millions
Latest funding date
01/01/2025
Location
Neko Health has successfully raised funds through multiple rounds, with the latest being a Series B round closed on January 22, 2025. The company is backed by five investors, including O.G. Venture Partners and Lakestar.
Keep reading to explore the intricacies of Neko Health's fundraising journey and the investors backing this innovative platform.
What Is Neko Health?
Neko Health, founded in 2018 by Daniel Ek and Hjalmar Nilsonne, is a health-tech company based in Stockholm, Sweden. The company focuses on developing advanced scanning technology for preventive healthcare and early detection of health issues.
With a team of 101-250 employees, Neko Health aims to make health checks convenient and affordable through non-invasive health data collection. Their innovative technology tracks various health metrics, including body measurements, blood vessels, and heart rhythm.
Neko Health operates health centers in Stockholm and London, providing comprehensive body scans that deliver instant results and detailed health analysis. Their doctor-led model of care emphasizes regular health checks to prioritize preventive health.
How Much Funding Has Neko Health Raised?
- Series A Funding
- Amount Raised: $65 million
- Date: July 2023
- Lead Investors: Lakestar, Atomico, General Catalyst
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the company's initial growth and development, allowing them to establish their services and begin scaling operations.
- Series B Funding
- Amount Raised: $260 million
- Date: January 2025
- Lead Investors: Lightspeed Venture Partners
- Valuation at Round: $1.8 billion
- Motivation Behind the Round: To accelerate the company's expansion within Europe and the US and to continue investing in research and development for new health diagnostics.
Total Amount Raised: $325 million. Current Valuation: $1.8 billion.
Key Investors
- Lightspeed Venture Partners
- Details: Lightspeed Venture Partners is a global venture capital firm that invests in the enterprise, consumer, and health sectors. Bejul Somaia, a partner at Lightspeed, will join Neko Health's Board of Directors.
- Investment Focus Areas: Enterprise, consumer, health sectors
- Notable Investments: Snapchat, GrubHub, Nest
- General Catalyst
- Details: General Catalyst is a venture capital firm that provides early-stage and growth equity investments. They focus on transformative investments that drive positive change.
- Investment Focus Areas: Early-stage, growth equity investments across various sectors
- Notable Investments: Airbnb, Stripe, Warby Parker
- O.G. Venture Partners
- Details: O.G. Venture Partners is a venture capital firm with a focus on early-stage investments. They participated in Neko Health's Series B funding round.
- Investment Focus Areas: Early-stage investments, particularly in technology
- Notable Investments: Specific notable investments not mentioned
- Lakestar
- Details: Lakestar is a European venture capital firm investing in technology companies. They have been involved with Neko Health since the Series A funding round.
- Investment Focus Areas: Technology companies, particularly in Europe
- Notable Investments: Spotify, Skype, Facebook
- Atomico
- Details: Atomico is a venture capital firm that invests in innovative technology companies globally. They participated in Neko Health's Series B funding round.
- Investment Focus Areas: Innovative technology companies globally
- Notable Investments: Klarna, Supercell, Lilium
What's Next for Neko Health?
With a global waiting list of over 100,000 people and 10,000 scans completed, Neko Health is poised for significant growth. The company plans to expand its operations within Europe and the US, leveraging the high demand for preventative healthcare services. This expansion presents a substantial opportunity to revolutionize the healthcare industry by making advanced diagnostics more accessible.
Future fundraising rounds are likely as Neko Health continues to scale and innovate. The involvement of high-profile investors like Lightspeed Venture Partners and General Catalyst indicates strong investor confidence. However, the company will need to manage the high demand and ensure the scalability of its technology while navigating regulatory requirements in new markets.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Neko Health and gather other critical business insights.
Sign up for free to start exploring the wealth of information available at Clay.
